地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18372041646
传真:17754422825
邮箱:sales@amyjet.com
<艾美捷科技代理Trialtusbioscience品牌全系列产品
TriAltus Bioscience是一个致力于为推动人类健康前沿的科学家服务的品牌。当今的创新者在推进基因疗法、工程诊断、早期疾病检测以及药物发现等领域,都需要高纯度、高性能且随时可以扩展的酶,TriAltus正是为此而存在。TriAltus的核心是其专有的CLiM™(CL7/Im7)纯化平台,是一种基于亲和标签的突破性系统,能在单个色谱步骤中提供具有卓越纯度、活性和一致性的酶,重新定义了重组蛋白纯化的可能性。 使用CLiM™生产的每种酶都以严格的质量控制、批次间一致性和详细的分析证书(COA)为后盾,旨在满足监管机构要求的质量和文档标准,支持从发现到扩大规模的更平稳过渡。TriAltus Bioscience公司的产品包括:基因组酶、蛋白酶和其他酶。

▍Trialtusbioscience产品线
● 基因组酶:TriAltus的重组基因组酶不含标签,并使用专有的CLiM™亲和标签系统进行纯化,提供目录酶的定制缩放和配方,以满足特定研究需求,无论需要更高的浓度、独特的缓冲条件还是批量生产,都可以根据具体规格定制酶。
| 货号 | 品名 | 规格 | 产品描述 |
| 40-1212 | AapCas12b Protein | 20 μg | expressed in E. coli and features two C-terminal nuclear localization signals,enables the inactive nuclease to be guided to the specific double stranded DNA site. |
| 40-1220 | AapCas12b Protein | 100 μg | |
| 40-1225 | AapCas12b Protein | 500 μg | |
| 40-1320 | CRISPR-Cas9 Protein | 100 μg | used for genome editing with CRISPR technology. Recombinant Streptococcus pyogenes Cas9 ,expressed in Escherichia coli and features two nuclear localization signals |
| 40-1325 | CRISPR-Cas9 Protein | 500 μg | |
| 40-2414 | Phi29 DNA Polymerase | 3,000 Units | a highly processive, isothermal enzyme from Bacillus subtilis phage phi29 ,with a robust 3'→5' proofreading exonuclease function. |
| 40-2420 | Phi29 DNA Polymerase | 10,000 Units | |
| 40-2125 | TAT-CRE Recombinase | 500 μg | used for site-specific DNA recombination in mammalian cells,a fusion protein combining a nuclear localization sequence, HIV-TAT cell permeabilization peptide, and Cre recombinase. |
| 40-2130 | TAT-CRE Recombinase | 1 mg | |
| 40-2135 | TAT-CRE Recombinase | 5 mg |
● 蛋白酶和其他酶:例如为冷冻电镜生成蛋白质的实验室提供SUMO蛋白酶,去除相关标签后蛋白质可进行分析,反应高效、稳健,无需优化,客户对酶的性能和优质客户服务感到满意。
| 货号 | 品名 | 规格 | 产品描述 |
| 30-2130 | PreScission Protease | 1 mg | recognizes and cleaves the sequence LEVLFQ/GP to release the target protein from the Im7-bound CL7 tag |
| 30-2135 | PreScission Protease | 5 mg | |
| 30-2140 | PreScission Protease | 10 mg | |
| 30-2146 | PreScission Protease | 50 mg | |
| 30-2150 | PreScission Protease | 100 mg | |
| 30-1130 | SUMO Protease | 1 mg | releases target proteins from TriAltus’s Im7 resin,recognizes SUMO tertiary structure – not a specific amino acid sequence – to cleave and release the target protein from the Im7-bound CL7 tag. |
| 30-1135 | SUMO Protease | 5 mg | |
| 30-1140 | SUMO Protease | 10 mg | |
| 30-1146 | SUMO Protease | 50 mg | |
| 30-1150 | SUMO Protease | 100 mg |

Gentarget拥有超过20年的生物试剂生产经验和超过15年的慢病毒工业应用经验。Gentarget研发出诸如SureTiter Lentiviral system , Optional inducible lentiviral system, Eco instant PCR cloning (Fusion in vivo) method等技术。
Incorporated in 2008, GenTarget provides proprietary bio-reagents and services with an emphasis on Lentivirus and Adenovirus gene delivery technologies, providing Pre-made Lentiviruses and Adenovirus for gene over-expression and knockdown and, and Pre-made mammalian stable cell lines.
With an emphasis on product quality and innovation, we develop and manufacture many proprietary technologies such as the such as SureTiterTM Lentiviral system; LocLightTMLive cell imaging, LoxP GFP/RFP ColorSwtich for CRE reproting system, and EcoTM instant PCR cloning method, as well as wide selection of Signal Transduction Pathway Report Lentivirus product series.
Gentarget的主要产品包括:
Premade Lentivirus
Premade stable cells
Recombinant Adenovirus
Control lentivirus
Premade shRNA lentivirus
microRNA lentivirus
anti miRNA lentivirus
Lentivectors
Ultra titer lentivirus
Reagents for lentivirus
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://biogradetech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="GenTarget"> GenTarget
Life Diagnostics公司专注于研发和生产临床前研究以及动物医学诊断相关的ELISA试剂盒、纯化的生物标志物和抗体等产品。产品覆盖心血管疾病、急性期反应、免疫毒性和免疫学标志物等研究领域,主要应用于小鼠、大鼠、兔、猫、狗、猪、猴和鸡等物种。此外,鉴于越来越多的研究围绕聚乙二醇化(PEGylated)生物制剂,Life Diagnostics公司也开发出了抗体PEG单克隆抗体和ELISA试剂盒用于检测PEG以及PEG化的蛋白。
Life Diagnostics manufactures ELISA kits, SPARCL™ kits, purified biomarkers and antibodies for preclinical research and veterinary diagnostics. Our areas of expertise include cardiovascular, acute phase, immunotoxicity and immunology biomarkers in species including mouse, rat, rabbit, cat, dog, pig, cow, monkey and chicken. Because of the increasing research into PEGylated biologics we have also developed anti-PEG monoclonal antibodies and ELISA kits for detection of PEG, mPEGylated proteins and anti-PEG antibodies. We manufacture all of the products listed on our website.
Life Diagnotics目前可提供用于检测骨骼肌肌钙蛋白-I(troponin-I)、肌红蛋白(myoglobin)、脂肪酸结合蛋白(fatty acid binding protein, FABP)以及肌球蛋白轻链(myosin light chain-1, MLC-1)等代表性标志分子的ELISA试剂盒;主要提供针对检测小鼠、大鼠、兔、狗、猪和猴等种属的检测试剂盒。与肌红蛋白蛋白和心脏型FABP不同,骨骼肌肌钙蛋白I特异性表达于骨骼肌细胞,因此为检测肌肉损伤的首选标志物分子。
Life Diagnotics生产的PEG试剂主要包括抗体、ELISA试剂盒以及PE化蛋白。
(1)PEG抗体
(2)PEG ELISA试剂盒:竞争法ELISA检测PEG化蛋白(含甲氧基,或不含甲氧基);夹心法ELISA快速检测甲氧基PEG(mPEG)和mPEG化蛋白;抗PEG IgG和IgM ELISA试剂盒用于检测小鼠、大鼠和猴血清或血浆中PEG抗体的水平。
(3)PEG化蛋白
此外,Life Diagnostics还提供PEG包被的微孔板和封闭缓冲液,专门设计用于免疫检测PEG或PEG化抗体。大多数商业化的ELISA试剂盒含有去垢剂如Tween-20(一种含有PEG的去垢剂)会干扰PEG的检测。Life Diagnostics公司提供的封闭缓冲液不含去垢剂和PEG, 可用于稳定包被有PEG或PEG抗体的平板。
Life Diagnostics除提供多种心肌标志物ELISA检测试剂盒之外,还生产多种纯化的心肌生物标志物蛋白,包括肌钙蛋白I、肌钙蛋白T、肌钙蛋白复合物、肌红蛋白和脂肪酸结合蛋白等,可提供来自不同物种包括人、小鼠、大鼠、豚鼠、兔、狗、猪、牛和猴的蛋白。
主要产品包括:
SPARCL Kits
Acute Phase Rgts. »
Cardiac Biomarkers »
Immunoglobulin Rgts. »
Immunotoxicity ELISA Kits
PEG Reagents »
Skeletal Muscle Rgts. »
Liver Biomarkers
Misc Biomarkers
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://biogradetech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Life Diagnostics"> Life Diagnostics
艾美捷科技特约代理Enzo Life Sciences公司产品。
Enzo Life Sciences主要产品包括Microarray Analysis(生物芯片分析类产品)、Modified Nucleotides(带修饰的核苷)、Nucleic Acid Labeling Systems(核苷酸标记系统)、Monoclonal Antibodies、Human Papillomavirus、Identification Systems(人乳头状瘤识别系统)、In Situ Hybridization And Detection Systems(原位杂交和检测系统)、BioProbe、Labeled Probes(生物标记探针)、Signal Generating Systems(信号发生系统)。
From Akt to ZBP1, Enzo provides a comprehensive set of solutions for your research. Use the links below to search for products by alphabetical or product type listing. Looking for something specific? Try the search bar above, then refine your search by product type, target, or application using the toolbox on the left.
Enzo Life Sciences的主要产品包括:
Microarray Analysis
Modified Nucleotides
Nucleic Acid Labeling Systems
Monoclonal Antibodies
Human Papillomavirus
Identification Systems
In Situ Hybridization And Detection Systems
BioProbe、Labeled Probes
Signal Generating Systems
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://biogradetech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Enzo Life Sicences"> Enzo Life Sicences
艾美捷科技代理Nanoanalytics品牌全系列产品
nanoAnalytics GmbH创立于1999年,是一家专业从事表面、界面和微观分析领域材料表征的公司,公司的主要产品包括全自动细胞跨膜电阻测量仪(CellZscope)以及cellQART耗材产品。该公司致力于为药物研发、毒理学、基础细胞生物学以及屏障功能研究提供强大的实时、无标记分析工具,以满足科研和工业界对体外细胞屏障模型功能定量评估日益增长的高标准需求。此外,NanoAnalytics公司还提供材料表征服务,运用尖端测量设备,实现微米至纳米量级的材料表面与界面分析。

▍cellZscope产品线
cellZscope®系列是专为非侵入式、自动化测量细胞层跨上皮电阻(TEER)和细胞层电容(Ccl)而设计的先进仪器系统。这些系统能够在模拟体内环境的生理条件下,对生长在多孔膜上的细胞层进行长期、连续且高度自动化的阻抗监测。其技术核心在于利用精密的阻抗分析技术,在尽可能不干扰细胞自然状态的情况下,获取反映细胞层完整性和功能的关键电生理参数。其具有以下特点:
● 提供精确的阻抗读数,兼容广泛使用的标准细胞培养耗材;
● 通过计算机软件实现便捷的数据记录、分析和实验控制;
● 不干扰细胞正常生长环境---测量的数值更加真实;
● 测量采用更宽的频率范围---拟合的数据更加精确;
● 构建的数理模型更加细致---电生理参数更加丰富。
| cZs E | cZs + | cZs 2 | cZs 3 | |
| Output parameters | TEER | TEER, Ccl | TEER, Ccl | TEER, Ccl |
| Number of wells | 6 | 24 | 24 | 24 (96§) |
| Supported insert sizes | 6-/12-/24-well | 6-/12-/24-well | 6-/12-/24-well | 6-/12-/24-well |
| Different insert sizes combinable | ✔ | ✔ | ✔ | ✔ |
| Works with standard cell culture inserts | ✔ | ✔ | ✔ | ✔ |
| Wells / Electrodes autoclavable | ✔ | ✔ | ✔ | ✔ |
| Measuring interval adjustable | ✔ | ✔ | ✔ | |
| High-speed measurement | ✔ | ✔ | ||
| Docking Station | ✔ | ✔ | ||
| Up to 4 Cell Modules per Controller | ✔ |
▍cellQART产品线
cellQART®是nanoAnalytics公司推出的一套专为配合其核心产品cellZscope®系统使用而设计的高品质、即用型耗材系统。cellQART®提供了多种规格的培养插板(Inserts),兼容标准的多孔板格式,其多孔膜材质(如 PET)和孔径大小经过优化,以满足不同类型细胞培养和精确阻抗测量的需求。
| 分类 | 货号 | Membrane Optics | Pore Size | Pore Density |
| 24-Well Inserts | 932 04 02 | translucent | 0.4 µm | 1×108 /cm2 |
| 24-Well Inserts | 932 04 12 | clear | 0.4 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 10 02 | translucent | 1.0 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 10 12 | clear | 1.0 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 30 02 | translucent | 3.0 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 30 12 | clear | 3.0 µm | 0.6×106 /cm2 |
| 24-Well Inserts | 932 50 02 | translucent | 5.0 µm | 0.6×106 /cm2 |
| 24-Well Inserts | 932 50 12 | clear | 5.0 µm | 0.6×106 /cm2 |
| 24-Well Inserts | 932 80 02 | translucent | 8.0 µm | 0.2×106 /cm2 |
| 24-Well Inserts | 932 80 12 | clear | 8.0 µm | 0.1×106 /cm2 |
| 24-Well Inserts | 932 04 04 | translucent | 0.4 µm | 1×108 /cm2 |
| 24-Well Inserts | 932 04 14 | clear | 0.4 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 10 04 | translucent | 1.0 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 10 14 | clear | 1.0 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 04 06 | translucent | 0.4 µm | 1×108 /cm2 |
| 24-Well Inserts | 932 04 16 | clear | 0.4 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 10 06 | translucent | 1.0 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 10 16 | clear | 1.0 µm | 2×106 /cm2 |
| 24-Well Inserts | 932 00 02 | - | - | - |
| 12-Well Inserts | 931 04 02 | translucent | 0.4 µm | 1×108 /cm2 |
| 12-Well Inserts | 931 04 12 | clear | 0.4 µm | 2×106 /cm2 |
| 12-Well Inserts | 931 10 02 | translucent | 1.0 µm | 2×106 /cm2 |
| 12-Well Inserts | 931 10 12 | clear | 1.0 µm | 2×106 /cm2 |
| 12-Well Inserts | 931 30 02 | translucent | 3.0 µm | 2×106 /cm2 |
| 12-Well Inserts | 931 30 12 | clear | 3.0 µm | 0.6×106 /cm2 |
| 12-Well Inserts | 931 50 02 | translucent | 5.0 µm | 0.6×106 /cm2 |
| 12-Well Inserts | 931 50 12 | clear | 5.0 µm | 0.6×106 /cm2 |
| 12-Well Inserts | 931 80 02 | translucent | 8.0 µm | 0.2×106 /cm2 |
| 12-Well Inserts | 931 80 12 | clear | 8.0 µm | 0.1×106 /cm2 |
| 12-Well Inserts | 931 04 04 | translucent | 0.4 µm | 1×108 /cm2 |
| 12-Well Inserts | 931 04 14 | clear | 0.4 µm | 2×106 /cm2 |
| 12-Well Inserts | 931 10 04 | translucent | 1.0 µm | 2×106 /cm2 |
| 12-Well Inserts | 931 10 14 | clear | 1.0 µm | 2×106 /cm2 |
| 6-Well Inserts | 930 04 02 | translucent | 0.4 µm | 1×108 /cm2 |
| 6-Well Inserts | 930 04 12 | clear | 0.4 µm | 2×106 /cm2 |
| 6-Well Inserts | 930 10 02 | translucent | 1.0 µm | 2×106 /cm2 |
| 6-Well Inserts | 930 10 12 | clear | 1.0 µm | 2×106 /cm2 |
| 6-Well Inserts | 930 30 02 | translucent | 3.0 µm | 2×106 /cm2 |
| 6-Well Inserts | 930 30 12 | clear | 3.0 µm | 0.6×106 /cm2 |
| 6-Well Inserts | 930 50 02 | translucent | 5.0 µm | 0.6×106 /cm2 |
| 6-Well Inserts | 930 50 12 | clear | 5.0 µm | 0.6×106 /cm2 |
| 6-Well Inserts | 930 80 02 | translucent | 8.0 µm | 0.2×106 /cm2 |
| 6-Well Inserts | 930 80 12 | clear | 8.0 µm | 0.1×106 /cm2 |
| 6-Well Inserts | 930 04 04 | translucent | 0.4 µm | 1×108 /cm2 |
| 6-Well Inserts | 930 04 14 | clear | 0.4 µm | 2×106 /cm2 |
| 6-Well Inserts | 930 10 04 | translucent | 1.0 µm | 2×106 /cm2 |
| 6-Well Inserts | 930 10 14 | clear | 1.0 µm | 2×106 /cm2 |

艾美捷科技特约代理Biosettia公司产品。
Biosettia公司专注于独特的技术开发和商业化生命科学的研究提供更好的解决方案,致力于提供创新的工具和特殊试剂,以帮助在全基因组功能分析和生成诱导多能干细胞(iPSC)。产品包括单链的RNA干扰相关,microRNA的表达相关,归一化全长cDNA文库和慢病毒传递系统。
Biosettia is a San Diego-based company that provides molecular biology products and services to support researchers worldwide. Using our highly efficient lentiviral system, we have assisted many academic institutes, biotech and pharmaceutical companies in doing gene expression & inhibition-related studies. Biosettia specializes in:
u Gene silencing by shRNA vector system
u Gene suppression by lentiviral miRNA
u Functionality screens by lentiviral miRNA
u miR-Locker – lentiviral miRNA inhibition
u Lentivirus production
u Lentiviral gene expression
u Induced pluripotent stem cell generation
u Nucleic acid purification
Biosettia公司的主要产品包括:
miRNA Expression & Inhibition
SORT shRNA Vector Systems
Lentiviral Labeling & Imaging
Lentiviral Packaging System
Cell Lines
Gene Expression
Stem Cell Research
Nucleic Acid Purification Kits
" data-original="http://biogradetech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理Biosettia公司产品"> 艾美捷科技特约代理Biosettia公司产品
艾美捷科技代理Nebulabio全系列药合成、递送及点击化学产品。
北京辰辉创聚生物技术有限公司(Nebula Biotechnology Co., Ltd.)是一家专注于创新药物研发关键试剂研发的高科技企业。自2022年成立以来,已推出药物标准品系列产品、抗体药参比试剂系列产品、活性小分子系列产品。公司已和全球近50家制药公司、药物研发机构、诊断试剂产品公司建立了友好的业务合作关系。
产品列表如下,欢迎咨询。
| 产品名称 | 货号 | 规格 | CAS号 |
| trans-Cyclooct-4-en-L-Lysine (EQUATORIAL) | NBS-230715 | 500mg; 1g | 1380349-88-1 |
| PrDiAzK | NBS-230716 | 100mg; 1g | 2231405-64-2 |
| exo-BCN-Fmoc-L-Lysine (BCN) | NBS-230717 | 500mg; 1g | 1493802-76-8 |
| DiAzK | NBS-230718 | 100mg; 1g | 1253643-88-7 |
| N3-Lys | NBS-230719 | 1g; 5g | 1167421-25-1 |
| cyclopropene-L-Lysine (CP) | NBS-230720 | 500mg; 1g | 1610703-09-7 |
| endo-BCN-Fmoc-L-Lysine (BCN) | NBS-230721 | 500mg; 1g | 1493802-95-1 |
| trans-Cyclooct-2-en-L-Lysine (TCO*A) | NBS-230722 | 500mg; 1g | 1801936-26-4 |
| exo BCN-L-Lysine | NBS-230723 | 500mg; 1g | 1384100-45-1 |
| Norbonene-CH2-L-Lysine (NBO) | NBS-230724 | 500mg | 1378916-76-7 (H+) |
| rac BCN-L-Lysine | NBS-230725 | 500mg; 1g; 5g | N/A |
| trans-Cyclooct-4-en-L-Lysine (AXIAL) | NBS-230726 | 500mg; 1g | 1380349-88-1 |
| endo BCN-L-Lysine | NBS-230727 | 500mg; 1g | 1493802-96-2 / 1580501-90-1 |
| PrK -HCl-salt | NBS-230728 | 1g; 5g | 1215204-46-8 (H+) // 1428330-91-9 (HCl) |
| SCO-L-Lysine-HCO2H-salt (purity 99%) | NBS-230729 | 10mg | 1309581-49-4 |
| SCO-L-Lysine-HCO2H-salt (purity 95%) | NBS-230730 | 500mg; 1g; 5g | 1309581-49-4 |
| TCO*A-OH (AXIAL) | NBS-230731 | 100mg; 1g | 1414375-00-0 |
| Me-Tet-PEG2-NH2 | NBS-230732 | 100mg; 500mg | N/A |
| Coumarin-PEG4-Tetrazine | NBS-230734 | 1mg; 5mg | N/A |
| Coumarin-C2-exoBCN | NBS-230735 | 1mg; 5mg | 2488174-17-8 |
| Coumarin-C2-TCO (axial) | NBS-230736 | 1mg; 5mg | 2488174-16-7 |
| (E)-cyclooctene doxorubicin conjugate (axial) | NBS-230738 | 10mg | 1438387-95-1 |
| SCO-NHS carbonate | NBS-230739 | 100mg; 1g | N/A |
| exo-BCN-NHS carbonate | NBS-230740 | 500mg; 1g | 1493802-77-9 |
| endo-BCN-NHS carbonate | NBS-230741 | 500mg; 1g | 1426827-79-3 |
| TCO4-NHS carbonate (EQUATORIAL) | NBS-230742 | 500mg; 1g | 1191901-33-3 |
| TCO4-NHS carbonate (AXIAL) | NBS-230743 | 500mg; 1g | 1191901-33-3 |
| TCO*-NHS carbonate (EQUATORIAL) | NBS-230744 | 500mg; 1g | 1610931-22-0 |
| TCO*-NHS carbonate (AXIAL) | NBS-230745 | 100mg; 1g | 1610931-22-0 |
| Tetrazine-Amine-TFA-salt | NBS-230746 | 100mg; 500mg | 1092689-33-2 |
| TCO*E-active ester (p-NPC, equatorial) | NBS-230747 | 100mg; 1g | 1580501-97-8 |
| exo BCN-OH | NBS-230850 | 500mg; 1g | 1263291-41-3 |
| SCO-active ester (p-NPE) | NBS-230851 | 500mg; 1g | 1309581-51-8 |
| SCO-OH | NBS-230852 | 500mg; 1g | 29916-92-5 |
| endo BCN-OH | NBS-230853 | 500mg; 1g | 1263166-90-0 |
| Aminopentyl-Tetrazine-HCl-salt | NBS-230854 | 100mg; 500mg | N/A |
| (E)-cyclooctene doxorubicin conjugate (EQUATORIAL) | NBS-230855 | 10mg | 1438387-96-2 |
| (E)-cyclooct-4-enol / equatorial-TCO / E | NBS-230856 | 100mg; 1g | 39637-79-1 |
| (E)-cyclooct-4-en active ester / TCO/E- active ester (p-NPE) (EQUATORIAL) | NBS-230857 | 100mg; 1g | 1354323-64-0 |
| (E)-cyclooct-4-en active ester / TCO4 / A- active ester (p-NPE) (AXIAL) | NBS-230858 | 100mg; 1g | 1438415-89-4 |
| (E)-cyclooct-4-enol / axial -TCO4 / A | NBS-230859 | 100mg; 1g | 39637-78-0 |
| Tetrazine active ester (Tetrazine-NHS) | NBS-230860 | 100mg; 500mg | 1384271-41-3 |
| Aminopropyl-Tetrazine-HCl-salt | NBS-230861 | 100mg; 500mg | 1146968-37-7 (H+) |
| N-Trifluoro-Acetylpropargylamine | NBS-230862 | 1g; 5g | 14719-21-2 |
| Methyl-Tetrazine-Amine- HCO2H-salt | NBS-230863 | 100mg; 500mg | 1345955-28-3 (H) |
| Tetrazine-Amine-HCO2H-salt | NBS-230864 | 100mg; 500mg | 1092689-33-2 (H) |
| TCO*A-OH (EQUATORIAL) | NBS-230865 | 100mg; 1g | 93301-75-8 |
| BCN-3,5-diene-9-methanol | NBS-230866 | 500mg; 1g | 1072439-47-4 |
| TCO*A-active ester (p-NPE) | NBS-230867 | 100mg; 1g | 1580501-97-8 |
| exo BCN-active ester (p-NPE) | NBS-230868 | 500mg | 1380006-72-3 |
| endo BCN-active ester (p-NPE) | NBS-230869 | 500mg; 1g | 1263166-91-1 |
| 12-Azidododecanoic acid | NBS-230876 | 100mg | 80667-36-3 |
| EdU | NBS-230877 | 100mg | 61135-33-9 |
| Pr-DiAz-OH | NBS-230878 | 100mg; 500mg | 1450754-41-2 |
| Pr-DiAz-NHSC | NBS-230879 | 100mg; 500mg | 2488239-96-7 |
| DiAz-NHSE | NBS-230880 | 100mg; 500mg | 1239017-80-1 |
| Pr-DiAz-NHSE | NBS-230881 | 100mg; 500mg | 2012552-32-6 |
| Pr-DiAz-COOH | NBS-230882 | 100mg; 500mg | 1450754-37-6 |
| Pr-DiAz-NH2 | NBS-230883 | 100mg; 500mg | 1450752-97-2 |
| Coumarin-PEG8-Tetrazine | NBS-230884 | 1mg; 5mg | N/A |
| Coumarin-PEG3-TCO* (AXIAL) | NBS-230885 | 1mg; 5mg | 2488319-02-2 |
| Coumarin-PEG7-TCO* (AXIAL) | NBS-230886 | 1mg; 5mg | N/A |
| Coumarin-PEG2-TCO* (AXIAL) | NBS-230891 | 1mg; 5mg | 2488174-19-0 |
| Coumarin-PEG2-exoBCN | NBS-230892 | 1mg; 5mg | 2488174-18-9 |
| Coumarin-PEG2-SCO | NBS-230893 | 1mg; 5mg | 2488239-94-5 |
| Coumarin-PEG2-endoBCN | NBS-230894 | 1mg; 5mg | 2488174-18-9 |
| Biotin-PEG3-CoenzymeA | NBS-230895 | 100µg; 1mg | N/A |
| Bis-Cyano-PEG9 | NBS-230896 | 100mg; 500mg | 41263-81-4 |
| Bis-Cyano-PEG5 | NBS-230897 | 100mg; 500mg | 41263-79-0 |
| Bis-Cyano-PEG4 | NBS-230898 | 100mg; 500mg | 57741-46-5 |
| N3-PEG8-t-butyl ester | NBS-230899 | 100mg; 1g | 1623791-99-0 |
| N3-PEG5-t-butyl ester | NBS-230900 | 100mg; 1g | 1415800-41-7 |
| N3-PEG4-t-butyl ester | NBS-230901 | 100mg; 1g | 581066-04-8 |
| N3-PEG3-t-butyl ester | NBS-230902 | 100mg; 1g | 252881-73-5 |
| Boc-N-Amido-PEG7-N3 | NBS-230903 | 100mg; 500mg | 206265-96-5 |
| Boc-N-Amido-PEG3-N3 | NBS-230904 | 100mg; 500mg | 642091-68-7 |
| Boc-N-Amido-PEG2-N3 | NBS-230905 | 100mg; 500mg | 950683-55-3 |
| Boc-N-Amido-PEG4-Alkyne | NBS-230906 | 100mg; 500mg | 1219810-90-8 |
| Boc-N-Amido-PEG3-Alkyne | NBS-230907 | 100mg; 500mg | 1333880-60-6 |
| Fluorescent-PEG8-Me-Tet | NBS-230908 | 5mg; 25mg | N/A |
| Fluorescent-PEG4-Me-Tet | NBS-230909 | 5mg; 25mg | N/A |
| Fluorescent-PEG3-Me-Tet | NBS-230910 | 5mg; 25mg | N/A |
| TAMRA-PEG8-Alkyne | NBS-230911 | 5mg; 25mg | N/A |
| TAMRA-PEG4-Alkyne | NBS-230912 | 5mg; 25mg | 1225057-68-0 |
| TAMRA-PEG3-Alkyne | NBS-230913 | 5mg; 25mg | N/A |
| TAMRA-PEG7-N3 | NBS-230914 | 5mg; 25mg | N/A |
| TAMRA-PEG3-N3 | NBS-230915 | 5mg; 25mg | 1228100-59-1 |
| TAMRA-PEG2-N3 | NBS-230916 | 5mg; 25mg | N/A |
| TAMRA-PEG8-COOH | NBS-230917 | 5mg; 25mg | N/A |
| TAMRA-PEG4-COOH | NBS-230918 | 5mg; 25mg | N/A |
| TAMRA-PEG3-COOH | NBS-230919 | 5mg; 25mg | N/A |
| TAMRA-PEG8-NHS | NBS-230920 | 5mg; 25mg | 2067281-44-9 |
| TAMRA-PEG4-NHS | NBS-230921 | 5mg; 25mg | N/A |
| TAMRA-PEG3-NHS | NBS-230922 | 5mg; 25mg | N/A |
| TAMRA-PEG7-Maleimide | NBS-230923 | 5mg; 25mg | N/A |
| TAMRA-PEG3-Maleimide | NBS-230924 | 5mg; 25mg | N/A |
| TAMRA-PEG2-Maleimide | NBS-230925 | 5mg; 25mg | N/A |
| TAMRA-PEG7-NH2 | NBS-230926 | 5mg; 25mg | N/A |
| TAMRA-PEG3-NH2 | NBS-230927 | 5mg; 25mg | N/A |
| TAMRA-PEG2-NH2 | NBS-230928 | 5mg; 25mg | 1425379-69-6 |
| Me-Tet-PEG8-NHBoc | NBS-230929 | 100mg; 500mg | 2143968-21-0 |
| Me-Tet-PEG4-NHBoc | NBS-230930 | 100mg; 500mg | 2143955-71-7 |
| Me-Tet-PEG3-NHBoc | NBS-230931 | 100mg; 500mg | 2141976-32-9 |
| Biotin-PEG8-Me-Tet | NBS-230932 | 100mg; 500mg | 2143958-82-9 |
| Biotin-PEG4-Me-Tet | NBS-230933 | 100mg; 500mg | 1962919-31-8 |
| Biotin-PEG3-Me-Tet | NBS-230934 | 100mg; 500mg | 2143968-06-1 |
| Me-Tet-PEG9-COOH | NBS-230935 | 100mg; 500mg | 2143964-70-7 |
| Me-Tet-PEG5-COOH | NBS-230936 | 100mg; 500mg | 2143964-72-9 |
| Me-Tet-PEG4-COOH | NBS-230937 | 100mg; 500mg | 2141976-30-7 |
| Me-Tet-PEG9-NHS | NBS-230938 | 100mg; 500mg | 2143955-78-4 |
| Me-Tet-PEG5-NHS | NBS-230939 | 100mg; 500mg | 2096446-25-0 |
| Me-Tet-PEG4-NHS | NBS-230940 | 100mg; 500mg | 2143968-22-1 |
| Me-Tet-PEG8-Maleimide | NBS-230941 | 100mg; 500mg | 2143968-05-0 |
| Me-Tet-PEG4-Maleimide | NBS-230942 | 100mg; 500mg | 1715913-76-0 |
| Me-Tet-PEG3-Maleimide | NBS-230943 | 100mg; 500mg | 2141976-31-8 |
| Me-Tet-PEG8-NH2-HCl salt | NBS-230944 | 100mg; 500mg | 2143958-58-9 (H+) |
| Me-Tet-PEG4-NH2 | NBS-230945 | 100mg; 500mg | 2055646-21-2 |
| Me-Tet-PEG3-NH2 | NBS-230946 | 100mg; 500mg | 2141976-28-3 |
| Biotin-PEG8-Alkyne | NBS-230947 | 100mg; 500mg | 2143968-80-1 |
| Biotin-PEG4-Alkyne | NBS-230948 | 100mg; 500mg | 1262681-31-1 |
| Biotin-PEG3-Alkyne | NBS-230949 | 100mg; 500mg | 1421701-68-9 |
| Biotin-PEG7-N3 | NBS-230950 | 100mg; 500mg | 1334172-75-6 |
| Biotin-PEG3-N3 | NBS-230951 | 100mg; 500mg | 875770-34-6 |
| Biotin-PEG2-N3 | NBS-230952 | 100mg; 500mg | 945633-30-7 |
| Biotin-PEG8-COOH | NBS-230953 | 100mg; 500mg | 2143964-62-7 |
| Biotin-PEG4-COOH | NBS-230954 | 100mg; 500mg | 721431-18-1 |
| Biotin-PEG3-COOH | NBS-230955 | 100mg; 500mg | 252881-76-8 |
| Biotin-PEG8-NHS | NBS-230956 | 100mg; 500mg | 2143968-03-8 |
| Biotin-PEG4-NHS | NBS-230957 | 100mg; 500mg | 459426-22-3 |
| Biotin-PEG3-NHS | NBS-230958 | 100mg; 500mg | 1253286-56-4 |
| Biotin-PEG7-Maleimide | NBS-230959 | 100mg; 500mg | 1898221-65-2 |
| Biotin-PEG3-Maleimide | NBS-230960 | 100mg; 500mg | 1431618-70-0 |
| Biotin-PEG2-Maleimide | NBS-230961 | 100mg; 500mg | 305372-39-8 |
| Biotin-PEG7-NH2 | NBS-230962 | 100mg; 500mg | 1334172-76-7 |
| Biotin-PEG3-NH2 | NBS-230963 | 100mg; 500mg | 359860-27-8 |
| Biotin-PEG2-NH2 | NBS-230964 | 100mg; 500mg | 138529-46-1 |
| TCO4-PEG8-COOH | NBS-230965 | 100mg; 500mg | N/A |
| TCO*-PEG8-COOH | NBS-230966 | 100mg; 500mg | N/A |
| TCO*-PEG4-COOH | NBS-230967 | 100mg; 500mg | N/A |
| TCO4-PEG4-COOH | NBS-230968 | 100mg; 500mg | 1802913-21-8 |
| TCO4-PEG3-COOH | NBS-230969 | 100mg; 500mg | 2141981-86-2 |
| TCO*-PEG3-COOH | NBS-230970 | 100mg; 500mg | N/A |
| TCO*-PEG8-NHS | NBS-230971 | 100mg; 500mg | N/A |
| TCO4-PEG8-NHS | NBS-230972 | 100mg; 500mg | N/A |
| TCO4-PEG4-NHS | NBS-230973 | 100mg; 500mg | 1621096-79-4 |
| TCO*-PEG4-NHS | NBS-230974 | 100mg; 500mg | N/A |
| TCO*-PEG3-NHS | NBS-230975 | 100mg; 500mg | N/A |
| TCO4-PEG3-NHS | NBS-230976 | 100mg; 500mg | 2141981-88-4 |
| TCO*-PEG7-Maleimide | NBS-230977 | 100mg; 500mg | N/A |
| TCO*-PEG3-Maleimide | NBS-230978 | 100mg; 500mg | 2392039-23-3 |
| TCO*-PEG2-Maleimide | NBS-230979 | 100mg; 500mg | N/A |
| TCO4-PEG7-Maleimide | NBS-230980 | 100mg; 500mg | N/A |
| TCO4-PEG3-Maleimide | NBS-230981 | 100mg; 500mg | 1914971-04-2 |
| TCO4-PEG2-Maleimide | NBS-230982 | 100mg; 500mg | 2141981-85-1 |
| TCO*-PEG2-NH2 | NBS-230983 | 100mg; 500mg | N/A |
| TCO*-PEG3-NH2 | NBS-230984 | 100mg; 500mg | N/A |
| TCO*-PEG7-NH2 | NBS-230985 | 100mg; 500mg | N/A |
| TCO4-PEG7-NH2 | NBS-230986 | 100mg; 500mg | N/A |
| TCO4-PEG3-NH2 | NBS-230987 | 100mg; 500mg | 1800507-93-0 |
| TCO4-PEG2-NH2 | NBS-230988 | 100mg; 500mg | N/A |
| SCO-PEG7-Maleimide | NBS-230989 | 100mg; 500mg | 2143968-81-2 |
| SCO-PEG3-Maleimide | NBS-230990 | 100mg; 500mg | 2141976-35-2 |
| SCO-PEG2-Maleimide | NBS-230991 | 100mg; 500mg | 2141976-23-8 |
| BCN-exo-PEG7-Maleimide | NBS-230992 | 100mg; 500mg | N/A |
| BCN-exo-PEG3-Maleimide | NBS-230993 | 100mg; 500mg | N/A |
| BCN-exo-PEG2-Maleimide | NBS-230994 | 100mg; 500mg | 2141976-22-7 |
| BCN-endo-PEG7-Maleimide | NBS-230995 | 100mg; 500mg | N/A |
| BCN-endo-PEG3-Maleimide | NBS-230996 | 100mg; 500mg | 2141976-33-0 |
| BCN-endo-PEG2-Maleimide | NBS-230997 | 100mg; 500mg | N/A |
| BCN-exo-PEG8-COOH | NBS-230998 | 100mg; 500mg | N/A |
| BCN-exo-PEG4-COOH | NBS-230999 | 100mg; 500mg | 1421932-54-8 |
| BCN-exo-PEG3-COOH | NBS-231000 | 100mg; 500mg | 1807501-82-1 |
| BCN-exo-PEG8-NHS | NBS-231001 | 100mg; 500mg | N/A |
| BCN-exo-PEG4-NHS | NBS-231002 | 100mg; 500mg | N/A |
| BCN-exo-PEG3-NHS | NBS-231003 | 100mg; 500mg | 2101206-94-2 |
| BCN-endo-PEG3-NHS | NBS-231004 | 100mg; 500mg | 2101206-94-2 |
| BCN-endo-PEG4-NHS | NBS-231005 | 100mg; 500mg | 1702356-19-1 |
| BCN-endo-PEG8-NHS | NBS-231006 | 100mg; 500mg | 1608140-48-2 |
| BCN-endo-PEG8-COOH | NBS-231007 | 100mg; 500mg | N/A |
| BCN-endo-PEG4-COOH | NBS-231008 | 100mg; 500mg | 1881221-47-1 |
| BCN-endo-PEG3-COOH | NBS-231009 | 100mg; 500mg | 1807501-82-1 |
| SCO-PEG3-COOH | NBS-231010 | 100mg; 500mg | 2141976-36-3 |
| SCO-PEG4-COOH | NBS-231011 | 100mg; 500mg | 2141976-27-2 |
| SCO-PEG8-COOH | NBS-231012 | 100mg; 500mg | 2143968-79-8 |
| SCO-PEG8-NHS | NBS-231013 | 100mg; 500mg | 2143968-68-5 |
| SCO-PEG4-NHS | NBS-231014 | 100mg; 500mg | 2141976-26-1 |
| SCO-PEG3-NHS | NBS-231015 | 100mg; 500mg | 2141976-25-0 |
| SCO-PEG7-NH2 | NBS-231016 | 100mg; 500mg | 2141976-35-2 |
| SCO-PEG3-NH2 | NBS-231017 | 100mg; 500mg | 2141976-29-4 |
| SCO-PEG2-NH2 | NBS-231018 | 100mg; 500mg | 2141976-34-1 |
| BCN-exo-PEG2-NH2 | NBS-231019 | 100mg; 500mg | 1357379-13-5 |
| BCN-exo-PEG3-NH2 | NBS-231020 | 100mg; 500mg | 1841134-72-2 |
| BCN-exo-PEG7-NH2 | NBS-231021 | 100mg; 500mg | 2143968-34-5 |
| BCN-endo-PEG7-NH2 | NBS-231022 | 100mg; 500mg | 2143968-34-5 |
| BCN-endo-PEG3-NH2 | NBS-231023 | 100mg; 500mg | 1883512-27-3 |
| BCN-endo-PEG2-NH2 | NBS-231024 | 100mg; 500mg | 1263166-93-3 |
| PEG-12 | NBS-231025 | 1g; 10g; bulk | 6790-09-6 |
| PEG-11 | NBS-231026 | 1g; 10g; bulk | 6809-70-7 |
| PEG-10 | NBS-231027 | 1g; 10g; bulk | 5579-66-8 |
| PEG-9 | NBS-231028 | 1g; 10g; bulk | 3386-18-3 |
| PEG-8 | NBS-231029 | 1g; 10g; 100g; 1kg; bulk | 5117-19-1 |
| Alkyne-PEG2-TCA | NBS-231030 | 100mg | 1281695-03-1 |
| Azido-PEG2-TCA | NBS-231031 | 100mg | 1281695-02-0 |
| Alkyne-PEG2-CM | NBS-231032 | 100mg | 1281695-01-9 |
| Azido-PEG2-CM | NBS-231033 | 100mg | 1281695-00-8 |
| Alkyne-PEG2 | NBS-231034 | 100mg | 7218-43-1 |
| Azido-PEG1 | NBS-231035 | 100mg | 139115-90-5 |
| 2-Methyl-Glycerol | NBS-231036 | 10g; 100g | 25245-58-3 |
| 2-Stearoyl glycerol | NBS-231037 | 20mg; 100mg | 621-61-4 |
| 2-Palmitoyl glycerol | NBS-231038 | 20mg; 100mg | 23470-00-0 |
| 2-Myristoyl glycerol | NBS-231039 | 20mg; 100mg | 3443-83-2 |
| 2-Lauroyl glycerol | NBS-231040 | 20mg; 100mg | 1678-45-1 |
| 2-Linoleoyl glycerol | NBS-231041 | 100 mmol solution in ACN | 3443-82-1 |
| 2-Oleoyl-glycerol | NBS-231042 | 10mg; 100mg | 3443-84-3 |
| SH-6 | NBS-231043 | 1mg; 5mg | 701976-55-8 |
| SH-5 | NBS-231044 | 1mg; 5mg | 701976-54-7 |
| Ins(345)P3*3Na | NBS-231045 | 1mg | 112791-62-5 (H) / 911105-38-9 (6 Na) |
| Ins(1)P*2K | NBS-231046 | 5mg | 313263-16-0 / 15421-51-9 (H) |
| myo-Inositol-trispyrophosphate | NBS-231047 | 100mg | 623552-11-4 / 802590-64-3 / 23103-35-7 |
| Ins(123456)P6 | NBS-231048 | 5g; 25g | 83-86-3 / 14306-25-3 (sodium salt) |
| Ins(23456)P5*10Na | NBS-231049 | 1mg | 109526-12-7 (8Na) / 25663-09-6 (H+) |
| Ins(13456)P5*10Na | NBS-231050 | 1mg | 20298-95-7 (H+) |
| Ins(12456)P5*10Na | NBS-231051 | 1mg | 183075-26-5 / 20298-94-6 (H+) |
| Ins(12356)P5*10Na | NBS-231052 | 1mg | 109526-12-7 (8Na) / 25663-09-6 (H+) |
| Ins(12345)P5*10Na | NBS-231053 | 1mg | 183075-27-6 / 20298-96-8 (H+) |
| Ins(1345)P4*8Na | NBS-231054 | 1mg | 135269-51-1 (H+: 99610-76-1) |
| Ins(136)P3*6Na | NBS-231055 | 1mg | 93133-75-6 (H) |
| Ins(134)P3*6K | NBS-231056 | 1mg; 5mg | 140385-74-6 / 98102-63-7 (H) / 145920-23-6 (6Na) |
| Ins(345)P3*3K | NBS-231057 | 1mg | 348128-32-5 / 112791-62-5 (H) / 348128-47-2 (x*K) |
| Ins(145)P3*6K | NBS-231058 | 5mg | 103476-24-0 / 85166-31-0 (H) |
| Ins(145)P3*3Li | NBS-231059 | 5mg | 129828-69-9 / 85166-31-0 (H) |
| Ins(145)P3*6Na | NBS-231060 | 5mg | 108340-81-4 / 85166-31-0 (H) |
| Ins(135)P3*6Na | NBS-231061 | 1mg | N/A |
| Ins(1245)P4*8Na | NBS-231062 | 1mg | 170715-18-1 (H+: 117142-45-7) |
| Bt3-Ins(356)P3 / PM | NBS-231063 | 1 µmol | N/A |
| Bt3-Ins(346)P3 / PM | NBS-231064 | 1 µmol | 503158-16-5 |
| Bt3-Ins(146)P3 / PM | NBS-231065 | 1 µmol | 503158-17-6 |
| Bt3-Ins(135)P3 / PM | NBS-231066 | 1 µmol | 503158-15-4 |
| Bt2-Ins(3456)P4 / PM | NBS-231067 | 1 µmol | 1233512-98-5 |
| Bt2-Ins(1456)P4 / PM | NBS-231068 | 1 µmol | N/A |
| Bt2-Ins(1345)P4 / PM | NBS-231069 | 1 µmol | 503158-20-1 |
| Bt2-Ins(1356)P4 / AM | NBS-231070 | 1 µmol | 164199-43-3 |
| Bt3-Ins(356)P3 / AM | NBS-231071 | 1 µmol | 164199-42-2 |
| Bt3-Ins(346)P3 / AM | NBS-231072 | 1 µmol | 431900-03-7 |
| Bt3-Ins(146)P3 / AM | NBS-231073 | 1 µmol | 431900-02-6 |
| Bt3-Ins(134)P3 / AM | NBS-231074 | 1 µmol | 205247-51-4 |
| Bt3-Ins(136)P3 / AM | NBS-231075 | 1 µmol | N/A |
| Bt3-Ins(135)P3 / AM | NBS-231076 | 1 µmol | 1258008-22-8 |
| Bt3-Ins(145)P3 / AM | NBS-231077 | 1 µmol | 164007-69-6 (196954-45-7) |
| caged-Ins(145)P3 / PM | NBS-231078 | 10 * 10 µg | 1009832-82-9 |
| caged-Ins(145)P3 / PM | NBS-231079 | 100 µg | 1009832-82-9 |
| caged-Ins(145)P3O6 | NBS-231080 | 100 µg | 887903-55-1 (H+) |
| caged-Ins(145)P3 P4 | NBS-231081 | 100 µg | 119147-20-5 / 132204-31-0 |
| PtdIns(345)P3 | NBS-231082 | 1mg | 165689-82-7 |
| PtdIns(45)P2 | NBS-231083 | 1mg | 120595-88-2 / 213596-15-7 |
| PtdIns(34)P2 | NBS-231084 | 1mg | 165883-85-2 |
| PtdIns(5)P | NBS-231085 | 1mg | 291527-75-8 |
| PtdIns(4)P | NBS-231086 | 1mg | 57606-15-2 |
| PtdIns(3)P | NBS-231087 | 1mg | 165689-81-6 |
| PtdIns(1)P | NBS-231088 | 1mg | 62742-56-7 / 28366-80-5 |
| D-myo-Inositol-1,2-O-cyclohexylidene | NBS-231089 | 1g | 55123-25-6 (rac: 6763-47-9) |
| 23:45-diisopropylidene-myo-Inositol | NBS-231090 | 1g | 211294-75-6 |
| 12:56- diisopropylidene-myo-Inositol | NBS-231091 | 1g | 211294-79-0 |
| D-myo-Inositol-2,3-O-cyclohexylidene | NBS-231092 | 1g | 57029-87-5 |
| 2,3:4,5-Di-O-Iso-1,6-Di-O-Benzyl-Ins | NBS-231093 | 1g | 131233-62-0 / 1266500-90-6 |
| 1,2:5,6-Di-O-Iso-3,4-Di-O-Benzyl-Ins | NBS-231094 | 1g | 131233-62-0 / 1266500-90-6 |
| DEAC-dUTP | NBS-231095 | 25 nmol; 100 nmol | N/A |
| 35-PAPS-TEA | NBS-231096 | 5mg | 936827-87-1 |
| ACPPS-TEA | NBS-231097 | 5mg | 102029-54-9 / 62230-90-4 |
| 25-PAPS-Li | NBS-231098 | 5mg | 62230-89-1 / 102029-54-9 |
| 35-PAPS-Li (CAS: 102029-54-9) | NBS-231099 | 5mg | 102029-54-9 / 482-67-7 (H+) |
| EdUTP-TEA | NBS-231100 | 1mg | 1191275-46-3 |
| EdUTP | NBS-231101 | 1mg | 111289-87-3 |
| 2'-PAP | NBS-231102 | 10mg; 50mg | 3805-37-6 |
| 2'-PAP-Na | NBS-231103 | 10mg; 50mg | 108347-94-0 |
| 3'-PAP-Na | NBS-231104 | 10mg; 50mg | 75431-54-8 |
| 3'-PAP | NBS-231105 | 10mg; 50mg | 1053-73-2 |
| Vancomycin hexapeptide | NBS-231106 | 5mg; 10mg | 115236-65-2 |
| Didechloro Vancomycin | NBS-231107 | 20mg; 100mg | 98510-30-6 |
| Vancomycin Impurity A | NBS-231108 | 20mg; 100mg | 91700-98-0 |
| Vancomycin Impurity D | NBS-231109 | 5mg; 10mg | 101485-50-1 |
| Vancomycin Impurity C | NBS-231110 | 5mg; 10mg | 82198-76-3 |
| Vancomycin Impurity B | NBS-231111 | 20mg; 100mg | 55598-85-1 |
| INO-4995 | NBS-231112 | 1mg; 10mg | 868171-91-9 |
| Podophyllotoxin Derivate | NBS-231113 | 100mg | 6559-91-7 |
| Podophyllotoxin Derivate | NBS-231114 | 10mg | 117507-84-3 |
| Clopidogrel Impurity 4 | NBS-231115 | 100mg | 144457-43-2 |
| Gestodene Impurity E | NBS-231116 | 1mg; 10mg | N/A |
| Fidaxomicin Metabolite OP-1118 | NBS-231117 | 1mg; 10mg | 1030825-28-5 |
| Prasugrel metabolite M6-d3 (stabilzed) | NBS-231118 | 1mg | 1234692-58-0 (without d3) |
| Prasugrel metabolite M6 | NBS-231119 | 10mg | 947530-51-0 |
| Clopidogrel Impurity C | NBS-231120 | 10mg | 1346605-15-9 |
| Clopidogrel Impurity 3 | NBS-231121 | 10mg | 141109-18-4 |
| Prasugrel active metabolite M3 HCl (stabilized) | NBS-231122 | 1mg; 5mg | 1287383-06-5 |
| Fidaxomicin-d7 | NBS-231123 | 1mg; 10mg | 873857-62-6 (unlabeled) |
| Methyl 4-(2-hydroxyethyl)benzoate-13C6,2D (Ring-13C6,Ethyl-1,2-D2) | NBS-231124 | 10mg | N/A |
| Anthracene 13C6 | NBS-231125 | 10mg | 189811-60-7 |
| Phenanthrene 13C6 | NBS-231126 | 10mg | 1189955-53-0 |
| Naphthalene 13C10 | NBS-231127 | 10mg | 219526-41-7 |
| Naphthalene 13C6 | NBS-231128 | 10mg | 1192501-11-3 |
| Prasugrel active metabolite M3-d3 (stabilzed) | NBS-231129 | 1mg; 5mg | 1619986-66-1 / 1226870-93-4 (without HCl) |
| 2-Cyanoethyl N,N-diisopropylchlorophosphoramidite | NBS-231130 | 10g | 89992-70-1 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(2-cyanoethyl) ester | NBS-231131 | 5g | 102690-88-0 |
| Phosphoramidous acid, N,N-bis(1-methylethyl)-, bis(phenylmethyl) ester | NBS-231132 | 10g | 108549-23-1 |
| Phosphorodiamidous acid. N.N.N'.N'-tetrakis(1-methylethyl)-. phenylmethyl ester | NBS-231133 | 1g | 108549-21-9 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. 2-cyanoethyl [1-(2-nitrophenyl)ethyl] ester) | NBS-231134 | 100mg | 461425-49-0 |
| Dichloro N,N-Diisopropylphosphoramidite | NBS-231135 | 10g | 921-26-6 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(9H-fluoren-9-ylmethyl) ester | NBS-231136 | 1g; 5g; 10g | 197709-11-8 |
| Di-tert-butyl chloromethyl phosphate | NBS-231137 | 1g | 229625-50-7 |
| Di-benzyl chloromethyl phosphate | NBS-231138 | 1g | 258516-84-6 |
| Ethyl 2-methyl-3-(trimethylsilyl)cycloprop-2-ene-1-carboxylate | NBS-231139 | 1g | 33002-26-5 |
| NOTA-Evans Blue / NEB | NBS-231140 | 1mg; 10mg | N/A |
| CoA-Cy5 | NBS-231141 | 1mg | N/A |
| CoA-Cy3 | NBS-231142 | 1mg | N/A |
| TMe-OHB-DAZA | NBS-231143 | 1mg; 10mg | 2241024-76-8 |
| NEmo2E | NBS-231144 | 10 µL; 50 µL | N/A |
| NEmo1 | NBS-231145 | 10 µL; 50 µL | N/A |
| Phycocyanobilin-PCB | NBS-231146 | 10mg; 25mg | 20298-86-6 |
| D-Serine-O-phosphate | NBS-231147 | 1g; 5g | 73913-63-0 |
| Ph-CCA-NH2 | NBS-231148 | 250mg | 129179-92-6 |
| Menaquinone 8 / MK 8:8 | NBS-231149 | 100 µg; 500 µg | 523-38-6 |
| Allyl-Maleimide | NBS-231150 | 100mg ; 500mg | 2973-17-3 |
| Nor-cisapride Derivative | NBS-231151 | 100mg; 1g | N/A |
| AlK-L-Lysine-HCl-salt | NBS-231152 | 2g; 5g | 6298-03-9 (H+) // 147529-99-5 (HCl) |
| 4-methyl-2,2-bis(trifluoromethyl)oxazolidin-5-one | NBS-231153 | 1g | 6458-31-7 |
| 3-(5-oxo-2,2-bis(trifluoromethyl)oxazolidin-4-yl)propanoic acid | NBS-231154 | 1g | 6458-51-1 |
| 7-(diethylamino)-4-(hydroxymethyl)-coumarin / DEACM | NBS-231155 | 100mg | 54711-38-5 |
| 3-bromo-4-methyl-7-(diethylamino)-coumarin | NBS-231156 | 100mg | 92295-93-7 |
| Xanthohumol | NBS-231157 | 10mg; 50mg | 6754-58-1 |
| IEPOX 4 | NBS-231158 | 5mg | 1189798-08-0 |
| IEPOX 3 | NBS-231159 | 5mg | 1189798-08-0 |
| 2-C-Methyl-L-Threitol | NBS-231160 | 5mg | 93921-84-7 |
| 2-C-Methyl-D-Threitol | NBS-231161 | 5mg | 310887-92-4 |
| 2-C-Methyl-L-Erythritol | NBS-231162 | 5mg | 93921-83-6 |
| 2-C-Methyl-D-Erythritol | NBS-231163 | 5mg | 58698-37-6 |
| 3-Amino-7-(diethylamino)-coumarine | NBS-231164 | 100mg; 500mg | 817638-67-8 |
| Chloromethylpropionate | NBS-231165 | 1g; 5g | 5402-53-9 |
| 2-(2-fluoro-2-methylpropoxy)-2-methylpropan-1-ol | NBS-231166 | 1g; 10g | 1823357-87-4 |
| 1,4-Di-butyryl-23:56-diisopropylidene-myo-Inositol | NBS-231167 | 0.5g; 1g | 1620222-02-7 |
| 3,6-Di-butyryl-12:45-diisopropylidene-myo-Inositol | NBS-231168 | 0.5g; 1g | 1307298-34-5 |
| Y-27632 | NBS-231169 | 50mg | 146986-50-7 |
| H-1152 | NBS-231170 | 10mg | 45146-2-58-1 |
| 3,4,5,6-Tetra-O-Benzyl-Ins | NBS-231171 | 1g | 24558-77-8 |
| 1,4,5,6-Tetra-O-Benzyl-Ins | NBS-231172 | 1g | 26276-99-3 |
| 2,5-Anhydro-6-azido-6-deoxy-1,3-O-isopropylidene-D-glucitol | NBS-231173 | 1g、5g、10g、25g、Bulk | N/A |
| 4-Azido-4-deoxy-1,6:2,3-dianhydro-β-D-mannopyranose | NBS-231174 | 1g、5g、10g、25g、Bulk | N/A |
| Methyl-3,6-anhydro-7-azido-2,7-dideoxy-4,5-O-isopropylidene-D-alloheptonate | NBS-231175 | 1g、5g、10g、25g、Bulk | N/A |
| 1,4-Anhydro-3-azido-2-O-benzoyl-3-deoxy-D-xylitol | NBS-231176 | 1g、5g、10g、25g、Bulk | N/A |
| 1,4-Anhydro-2-azido-3-O-benzoyl-2-deoxy-D-arabitol | NBS-231177 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,4;3,6-dianhydro-D-glucitol | NBS-231178 | 1g、5g、10g、25g、Bulk | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-D-galactopyranose | NBS-231179 | 1g、5g、10g、25g、Bulk | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-L-galactopyranose | NBS-231180 | 1g、5g、10g、25g、Bulk | N/A |
| DIBMA free acid | NBS-231181 | 1g、5g、10g、25g、Bulk | N/A |
| DIBMA monosodium salt | NBS-231182 | 1g、5g、10g、25g、Bulk | N/A |
| Glyco-DIBMA | NBS-231183 | 1g、5g、10g、25g、Bulk | N/A |
| n-Octyl α-D-glucopyranoside | NBS-231184 | 1g、5g、10g、25g、Bulk | 29781-80-4 |
| HECAMEG | NBS-231185 | 1g、5g、10g、25g、Bulk | 115457-83-5 |
| n-Hexyl β-D-glucopyranoside | NBS-231186 | 1g、5g、10g、25g、Bulk | 59080-45-4 |
| n-Heptyl β-D-glucopyranoside | NBS-231187 | 1g、5g、10g、25g、Bulk | 78617-12-6 |
| n-Octyl β-D-glucopyranoside | NBS-231188 | 1g、5g、10g、25g、Bulk | 29836-26-8 |
| n-Octyl β-D-glucopyranoside | NBS-231189 | 1g、5g、10g、25g、Bulk | 29836-26-8 |
| n-Nonyl β-D-glucopyranoside | NBS-231190 | 1g、5g、10g、25g、Bulk | 69984-73-2 |
| n-Nonyl β-D-glucopyranoside | NBS-231191 | 1g、5g、10g、25g、Bulk | 69984-73-2 |
| n-Decyl β-D-glucopyranoside (DG) > 99% highly purified | NBS-231192 | 1g、5g、10g、25g、Bulk | 58846-77-8 |
| n-Undecyl β-D-glucopyranoside (UDG) | NBS-231193 | 1g、5g、10g、25g、Bulk | 70005-86-6 |
| n-Dodecyl β-D-glucopyranoside | NBS-231194 | 1g、5g、10g、25g、Bulk | 59122-55-3 |
| 4-trans-(4-trans-Propylcyclohexyl)-cyclohexyl α-maltoside | NBS-231195 | 1g、5g、10g、25g、Bulk | N/A |
| n-Dodecyl α-maltoside | NBS-231196 | 1g、5g、10g、25g、Bulk | 116183-64-3 |
| n-Hexyl β-maltoside | NBS-231197 | 1g、5g、10g、25g、Bulk | 870287-95-9 |
| n-Heptyl β-maltoside | NBS-231198 | 1g、5g、10g、25g、Bulk | N/A |
| n-Octyl β-maltoside | NBS-231199 | 1g、5g、10g、25g、Bulk | 82494-08-4 |
| n-Nonyl β-maltoside | NBS-231200 | 1g、5g、10g、25g、Bulk | 106402-05-5 |
| n-Nonyl β-maltoside | NBS-231201 | 1g、5g、10g、25g、Bulk | 106402-05-5 |
| n-Decyl β-maltoside | NBS-231202 | 1g、5g、10g、25g、Bulk | 82494-09-5 |
| n-Decyl β-maltoside | NBS-231203 | 1g、5g、10g、25g、Bulk | 82494-09-5 |
| n-Undecyl β-maltoside | NBS-231204 | 1g、5g、10g、25g、Bulk | 253678-67-0 |
| n-Undecyl β-maltoside | NBS-231205 | 1g、5g、10g、25g、Bulk | 253678-67-0 |
| n-Dodecyl β-maltoside | NBS-231206 | 1g、5g、10g、25g、Bulk | 69227-93-6 |
| n-Tridecyl β-maltoside | NBS-231207 | 1g、5g、10g、25g、Bulk | 93911-12-7 |
| n-Tridecyl β-maltoside | NBS-231208 | 1g、5g、10g、25g、Bulk | 93911-12-7 |
| n-Tetradecyl β-maltoside | NBS-231209 | 1g、5g、10g、25g、Bulk | 18449-82-6 |
| n-Pentadecyl β-maltoside | NBS-231210 | 1g、5g、10g、25g、Bulk | N/A |
| n-Hexadecyl β-maltoside | NBS-231211 | 1g、5g、10g、25g、Bulk | 98064-96-1 |
| n-Dodecyl β-maltoside | NBS-231212 | 1g、5g、10g、25g、Bulk | 69227-93-6 |
| Isopropyl 1-thio-β-D-galactopyranoside | NBS-231213 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| n-Heptyl 1-thio-β-D-glucopyranoside | NBS-231214 | 1g、5g、10g、25g、Bulk | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside | NBS-231215 | 1g、5g、10g、25g、Bulk | 85618-21-9 |
| n-Nonyl 1-thio-β-D-glucopyranoside | NBS-231216 | 1g、5g、10g、25g、Bulk | 98854-15-0 |
| n-Decyl 1-thio-β-D-glucopyranoside | NBS-231217 | 1g、5g、10g、25g、Bulk | 98854-16-1 |
| n-Dodecyl 1-thio-β-maltoside | NBS-231218 | 1g、5g、10g、25g、Bulk | 148565-58-6 |
| n-Heptyl 1-thio-β-D-glucopyranoside | NBS-231219 | 1g、5g、10g、25g、Bulk | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside | NBS-231220 | 1g、5g、10g、25g、Bulk | 85618-21-9 |
| MEGA-8 | NBS-231221 | 1g、5g、10g、25g、Bulk | 85316-98-9 |
| MEGA-9 | NBS-231222 | 1g、5g、10g、25g、Bulk | 85261-19-4 |
| MEGA-10 | NBS-231223 | 1g、5g、10g、25g、Bulk | 85261-19-4 |
| 1-O-(n-Octyl)-tetraethyleneglycol | NBS-231224 | 1g、5g、10g、25g、Bulk | 19327-39-0 |
| 1-O-(n-Decyl)-hexaethyleneglycol (C10E6) | NBS-231225 | 1g、5g、10g、25g、Bulk | 5168-89-8 |
| 1-O-(n-Decyl)-nonaethyleneglycol | NBS-231226 | 1g、5g、10g、25g、Bulk | 26183-52-81 |
| 1-O-(n-Dodecyl)-tetraethyleneglycol | NBS-231227 | 1g、5g、10g、25g、Bulk | 5274-68-0 |
| 1-O-(n-Dodecyl)-octaethyleneglycol | NBS-231228 | 1g、5g、10g、25g、Bulk | 3055-98-9 |
| 1-O-(n-Dodecyl)-nonaethyleneglycol | NBS-231229 | 1g、5g、10g、25g、Bulk | 3055-99-0 |
| 1-O-(n-Dodecyl)-decaethyleneglycol | NBS-231230 | 1g、5g、10g、25g、Bulk | 6540-99-4 |
| 1-O-(n-Tridecyl)-octaethyleneglycol | NBS-231231 | 1g、5g、10g、25g、Bulk | 9043-30-5 |
| N,N-Dimethyl-n-dodecylamine-N-oxide | NBS-231232 | 1g、5g、10g、25g、Bulk | 1643-20-5 |
| Sucrose monolaurate | NBS-231233 | 1g、5g、10g、25g、Bulk | 25339-99-5 |
| Monoolein | NBS-231234 | 1g、5g、10g、25g、Bulk | 111-03-5 |
| 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propane sulfonate | NBS-231235 | 1g、5g、10g、25g、Bulk | 75621-03-3 |
| CHAPSO | NBS-231236 | 1g、5g、10g、25g、Bulk | 82473-24-3 |
| n-Nonylphosphocholine | NBS-231237 | 1g、5g、10g、25g、Bulk | 253678-64-7 |
| n-Decylphosphocholine | NBS-231238 | 1g、5g、10g、25g、Bulk | 70504-28-8 |
| n-Undecylphosphocholine | NBS-231239 | 1g、5g、10g、25g、Bulk | 253678-65-8 |
| n-Dodecylphosphocholine | NBS-231240 | 1g、5g、10g、25g、Bulk | 29557-51-5 |
| n-Tridecylphosphocholine | NBS-231241 | 1g、5g、10g、25g、Bulk | 85775-42-4 |
| n-Tetradecylphosphocholine | NBS-231242 | 1g、5g、10g、25g、Bulk | 77733-28-9 |
| n-Pentadecylphosphocholine | NBS-231243 | 1g、5g、10g、25g、Bulk | 146801-07-2 |
| n-Hexadecylphosphocholine | NBS-231244 | 1g、5g、10g、25g、Bulk | 58066-85-6 |
| α-D-Galactopyranose-phosphate di-potassium salt dihydrate | NBS-231245 | 1g、5g、10g、25g、Bulk | 19046-60-7 |
| α-D-Glucopyranose-phosphate di-potassium salt dihydrate | NBS-231246 | 1g、5g、10g、25g、Bulk | 5996-14-5 |
| α-D-Mannopyranose-phosphate di-potassium salt dihydrate | NBS-231247 | 1g、5g、10g、25g、Bulk | 71888-67-0 |
| N-Acetyl-D-galactosamine | NBS-231248 | 1g、5g、10g、25g、Bulk | 1811-31-0 |
| N-Acetyl-D-glucosamine | NBS-231249 | 1g、5g、10g、25g、Bulk | 7512-17-6 |
| 2-Acetamido-2-deoxy-β-D-glucopyranosylamin | NBS-231250 | 1g、5g、10g、25g、Bulk | 18615-50-4 |
| 2-Acetamido-2-deoxy-D-mannose monohydrate | NBS-231251 | 1g、5g、10g、25g、Bulk | 7772-94-3 |
| 1,3,4,6-tetra-O-acetyl-β-D-GlcNAc | NBS-231252 | 1g、5g、10g、25g、Bulk | 7772-79-4 |
| 3,4,6-tri-O-acetyl-β-D-GlcNAc azide | NBS-231253 | 1g、5g、10g、25g、Bulk | 6205-69-2 |
| 3,4,6-tri-O-acetyl-α-D-GlcNAc chlorid | NBS-231254 | 1g、5g、10g、25g、Bulk | 3068-34-6 |
| 1,3,4,6-tetra-O-acetyl-α-D-glucosamine x HCl | NBS-231255 | 1g、5g、10g、25g、Bulk | N/A |
| Allyl 2-acetamido-2-deoxy-α-D-glucopyranoside | NBS-231256 | 1g、5g、10g、25g、Bulk | 54400-75-8 |
| Allyl 2-acetamido-2-deoxy-β-D-glucopyranoside | NBS-231257 | 1g、5g、10g、25g、Bulk | 54400-77-0 |
| Allyl α-D-galactopyranoside | NBS-231258 | 1g、5g、10g、25g、Bulk | 48149-72-0 |
| Allyl α-D-glucopyranoside | NBS-231259 | 1g、5g、10g、25g、Bulk | 7464-56-4 |
| Allyl β-D-glucopyranoside | NBS-231260 | 1g、5g、10g、25g、Bulk | 34384-797 |
| Allyl α-D-mannopyranoside | NBS-231261 | 1g、5g、10g、25g、Bulk | 41308-76-3 |
| Allyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside | NBS-231262 | 1g、5g、10g、25g、Bulk | N/A |
| 1-Amino-1-deoxy-β-D-galactose | NBS-231263 | 1g、5g、10g、25g、Bulk | 50444-86-5 |
| 1,6-Anhydro-β-D-galactopyranose | NBS-231264 | 1g、5g、10g、25g、Bulk | 644-76-8 |
| 1,6:3,4-Dianhydro-2-O-tosyl--D-galactopyranose | NBS-231265 | 1g、5g、10g、25g、Bulk | 6167-32-4 |
| D-Arabinose | NBS-231266 | 1g、5g、10g、25g、Bulk | 28697-53-2 |
| Arbutin | NBS-231267 | 1g、5g、10g、25g、Bulk | 497-76-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-galactopyranose | NBS-231268 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α,β-D-galacto-pyranose | NBS-231269 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose | NBS-231270 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,2‘,3,3‘,4‘,6,6‘-hepta-O-acetyl-α,β-lactose | NBS-231271 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-mannopyranose | NBS-231272 | 1g、5g、10g、25g、Bulk | N/A |
| Benzyl 4,6-O-benzylidene-α-D-GlcNAc | NBS-231273 | 1g、5g、10g、25g、Bulk | 13343-63-0 |
| Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside | NBS-231274 | 1g、5g、10g、25g、Bulk | 13343-62-9 |
| Benzyl α-D-mannopyranoside | NBS-231275 | 1g、5g、10g、25g、Bulk | 155548-45-5 |
| Cellobiose | NBS-231276 | 1g、5g、10g、25g、Bulk | 528-50-7 |
| 6-Deoxy-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose | NBS-231277 | 1g、5g、10g、25g、Bulk | 4026-27-1 |
| 3,4-Di-O-acetyl-L-rhamnal | NBS-231278 | 1g、5g、10g、25g、Bulk | 34819-86-8 |
| 1,4:3,6-Dianhydro-D-mannitol | NBS-231279 | 1g、5g、10g、25g、Bulk | 641-74-7 |
| 1,2,3,4-Di-O-isopropylidene-α-D-galactopyranose | NBS-231280 | 1g、5g、10g、25g、Bulk | 4064-06-6 |
| 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose | NBS-231281 | 1g、5g、10g、25g、Bulk | 582-52-5 |
| 1,2:5,6-Di-O-isopropylidene-D-mannitol | NBS-231282 | 1g、5g、10g、25g、Bulk | 1707-77-3 |
| 2,3:5,6-Di-O-isopropylidene-α-D-mannofuranose | NBS-231283 | 1g、5g、10g、25g、Bulk | 14131-84-1 |
| 1,2:3,5-Di-O-isopropylidene-α-D-xylofuranose | NBS-231284 | 1g、5g、10g、25g、Bulk | 20881-04-3 |
| D-Fucose | NBS-231285 | 1g、5g、10g、25g、Bulk | 3615-37-0 |
| L-Fucose | NBS-231286 | 1g、5g、10g、25g、Bulk | 2438-80-4 |
| D-Galactosamine x HCl | NBS-231287 | 1g、5g、10g、25g、Bulk | 1172-03-8 |
| D-Glucosamine x HCl | NBS-231288 | 1g、5g、10g、25g、Bulk | 66-84-2 |
| L-Glucose | NBS-231289 | 1g、5g、10g、25g、Bulk | 921-60-8 |
| 2,3,3’,4,6,6’-Hexa-O-acetyl-lactal | NBS-231290 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2-O-Isopropylidene-α-D-glucofuranose | NBS-231291 | 1g、5g、10g、25g、Bulk | 18549-40-1 |
| Isopropyl-β-D-thiogalactoside | NBS-231292 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| Isopropyl-β-D-thiogalactoside | NBS-231293 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| 3,4-O-Isopropylidene-D-mannitol | NBS-231294 | 1g、5g、10g、25g、Bulk | 369-84-4 |
| 1,2-O-Isopropylidene-α-D-xylofuranose | NBS-231295 | 1g、5g、10g、25g、Bulk | 20031-21-4 |
| D-Lyxose | NBS-231296 | 1g、5g、10g、25g、Bulk | 1114-34-7 |
| L-Lyxose | NBS-231297 | 1g、5g、10g、25g、Bulk | 1949-78-6 |
| Maltose monohydrate | NBS-231298 | 1g、5g、10g、25g、Bulk | 6363-53-7 |
| β-Maltose octaacetate | NBS-231299 | 1g、5g、10g、25g、Bulk | 22352-19-8 |
| D-Mannose | NBS-231300 | 1g、5g、10g、25g、Bulk | 3458-28-4 |
| L-Mannose | NBS-231301 | 1g、5g、10g、25g、Bulk | 10030-80-5 |
| Methyl 4,6-O-benzylidene-β-D-galactopyranoside | NBS-231302 | 1g、5g、10g、25g、Bulk | 6988-39-2 |
| Methyl 4,6-O-benzylidene-α-D-glucopyranoside | NBS-231303 | 1g、5g、10g、25g、Bulk | 3162-96-7 |
| Methyl 4,6-O-benzylidene-β-D-glucopyranoside | NBS-231304 | 1g、5g、10g、25g、Bulk | 6988-39-2 |
| Methyl 6-deoxy-α-L-mannopyranoside | NBS-231305 | 1g、5g、10g、25g、Bulk | 15814-59-2 |
| Methyl α-D-fucopyranoside | NBS-231306 | 1g、5g、10g、25g、Bulk | 1128-40-1 |
| Methyl α-L-fucopyranoside | NBS-231307 | 1g、5g、10g、25g、Bulk | 14687-15-1 |
| Methyl β-D-galactopyranoside | NBS-231308 | 1g、5g、10g、25g、Bulk | 1824-94-8 |
| Methyl β-D-glucopyranoside hemihydrate | NBS-231309 | 1g、5g、10g、25g、Bulk | 7000-27-3 |
| Methyl β-D-ribopyranoside | NBS-231310 | 1g、5g、10g、25g、Bulk | 17289-61-1 |
| Methyl 2,3,5-tri-O-benzoyl-α-D-arabinofuranoside | NBS-231311 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2,3,4,6-Penta-O-acetyl-β-D-galactopyranose | NBS-231312 | 1g、5g、10g、25g、Bulk | 4163-60-4 |
| 1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranose | NBS-231313 | 1g、5g、10g、25g、Bulk | 4163-65-9 |
| D-Raffinose pentahydrate | NBS-231314 | 1g、5g、10g、25g、Bulk | 17629-30-0 |
| L-Rhamnose monohydrate | NBS-231315 | 1g、5g、10g、25g、Bulk | 10030-85-0 |
| D-Ribose | NBS-231316 | 1g、5g、10g、25g、Bulk | 50-69-1 |
| L-Ribose | NBS-231317 | 1g、5g、10g、25g、Bulk | 24259-59-4 |
| D-Tagatose | NBS-231318 | 1g、5g、10g、25g、Bulk | 87-81-0 |
| α-D-Talose | NBS-231319 | 1g、5g、10g、25g、Bulk | 2595-98-4 |
| 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide | NBS-231320 | 1g、5g、10g、25g、Bulk | 13992-26-2 |
| 2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromide | NBS-231321 | 1g、5g、10g、25g、Bulk | 3068-32-4 |
| 2,3,4,6-Tetra-O-acetyl--D-glucopyranosyl azide | NBS-231322 | 1g、5g、10g、25g、Bulk | 13992-25-1 |
| 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide | NBS-231323 | 1g、5g、10g、25g、Bulk | 572-09-8 |
| 1,3,4,6-Tetra-O-acetyl-β-D-mannopyranose | NBS-231324 | 1g、5g、10g、25g、Bulk | 18968-05-3 |
| 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranose | NBS-231325 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose | NBS-231326 | 1g、5g、10g、25g、Bulk | 13035-61-5 |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galactopyranose | NBS-231327 | 1g、5g、10g、25g、Bulk | N/A |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranose | NBS-231328 | 1g、5g、10g、25g、Bulk | 19879-84-6 |
| 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranose | NBS-231329 | 1g、5g、10g、25g、Bulk | 5308-25-7 |
| 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranose | NBS-231330 | 1g、5g、10g、25g、Bulk | 4132-28-9 |
| 2,3,4,6-Tetra-O-benzyl-α-D-mannopyranose | NBS-231331 | 1g、5g、10g、25g、Bulk | 61330-61-8 |
| 1-Thio-β-D-galactose sodium salt | NBS-231332 | 1g、5g、10g、25g、Bulk | 42891-22-5 |
| 1-Thio-β-D-glucose sodium salt dihydrate | NBS-231333 | 1g、5g、10g、25g、Bulk | 10593-29-0 |
| 3,4,6-Tri-O-acetyl-D-galactal | NBS-231334 | 1g、5g、10g、25g、Bulk | 4098-06-0 |
| D-Turanose | NBS-231335 | 1g、5g、10g、25g、Bulk | 547-25-1 |
| D-Xylose | NBS-231336 | 1g、5g、10g、25g、Bulk | 58-86-6 |
| 1,6-Anhydro-β-D-glucopyranose | NBS-231337 | 1g、5g、10g、25g、Bulk | 498-07-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose | NBS-231338 | 1g、5g、10g、25g、Bulk | N/A |


OXOID的主要产品包括:
Agars
Air Sampler
Antimicrobial Susceptibility Discs In Cartridges
Antimicrobial Susceptibility Testing
Atmosphere Generation System
Biochemical Reagents
Blood Culture
Culti-Loops
Culture Media Supplements
Dehydrated Culture Media
Diagnostic Discs
Diagnostic Reagents
Dip Slides
EIA Test Components Veterinary
EIA Test Veterinary
Food Allergen tests
IDEIA Accessories
IDEIA EIA Test
IMAGEN Accessories
IMAGEN Immunofluorescence Test
Laboratory Preparations/Biological Extracts
Microbact Biochemical Identification Kits
Molecular Microbiology
Oxoid Biochemical Identification System (O.B.I.S.)
Prepared Media
Prepared Media - Bottled Culture Media
Prepared Media - Ready Prepared Plates
Publications
Quanti-Cult
Rapid Food Tests
Remel - Agglutinating Sera
Remel - Collection and Transport
Remel - Diagnostic Kits
Remel - Diagnostic Tests
Remel - Laboratory Supplies
Remel - Quality Control
Remel - Reagents and Stains
Remel - Stained Suspensions
Test Tube Caps
Toxin Detection Kits
Transport Swabs
Veggietones
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
<艾美捷科技代理MicroFIT品牌全系列产品
MicroFIT是一家在生物/医疗领域具有显著影响力的企业,专注于基于模拟人体环境和组织的平台技术,致力于为生物医疗领域提供创新的产品和服务。公司以成为“基于Bio-Convergence技术的仿生平台领先企业”为目标,不断探索和研发,旨在成长为一家提供个性化医疗所需仿生平台的全球性公司。

▍MicroFIT产品线
● StemFIT 3D-Plastic系列
StemFIT 3D-Plastic系列产品采用PS(聚苯乙烯)材料设计,融合了多种实用功能,旨在使大规模3D细胞培养变得更加容易、高效和经济。能广泛应用于再生医学、精准医疗、疾病建模、发育生物学、毒物学、宿主-微生物组相互作用、药物发现和基因编辑等多个领域。
| 型号 | H389600P-6 孔 | H389600P-单人 |
| 材料 | 聚苯乙烯 | 聚苯乙烯 |
| 特征 | 大规模培养, 经济实惠,易于移液, 疏水性 | 大众培养, 经济实惠,易于移液, 疏水性 |
| 井数量 | 每个 2,334 | 389 个 |
| 井径 | 600 微米 | 600 微米 |
| 单元格数量 | ≥ 1.2 x 106 | ≥ 1.2 x 106 |
| 细胞接种培养基的体积 | 1 毫升 | 1 毫升 |
| 细胞培养基体积 | 3 ~ 8 毫升 | 3 毫升 |
| 包装 | 3 包/箱 | 20 个 EA/CS,40 个 EA/CS |
● StemFIT 3D®
StemFIT 3D®是一款创新性的三维细胞培养板,带有凹形微孔的微孔板,其核心原理在于利用这些微孔将孔内的细胞浓缩,进而培养细胞聚集体。使细胞能够在三维空间内相互作用,更好地模拟了体内细胞的生长环境。StemFIT 3D®在三个维度上形成细胞聚集体,允许细胞向各个方向生长并与周围环境相互作用,通过扩散和传递为细胞提供营养、氧气和药物,从而提供更接近生物体真实情况的仿生环境。
| 型号 | 井型 | 井数 | 井径 | 细胞数量 | 播种培养基体积 | 总培养基体积 |
| H1613200 | Hexagon | 1613 | 200 μm | ≥ 6.0 x 105 | 500 μl | 1 ml |
| H853400 | Hexagon | 853 | 400 μm | ≥ 1.2 x 106 | 1 ml | 1.5 ml |
| H389600L/H389600H | Hexagon | 389 | 600 μm | ≥ 1.2 x 106 | 1 ml | H389600L-1.3 ml;H389600H-1.7 ml |
| H449800 | Hexagon | 449 | 800 μm | ≥ 2.4 x 106 | 1 ml | 4 ml |
| H2951000 | Hexagon | 295 | 1000 μm | ≥ 2.4 x 106 | 2 ml | 4 ml |
| C100600 | Circle | 100 | 600 μm | ≥ 6.0 x 105 | 2 ml | 700 μl |
| C163000 | Circle | 16 | 3,000 μm | 2.5 x 105 / well | 20 μl / well | 5 ml |
| C253000 | Circle | 25 | 3,000 μm | 2.5 x 105 / well | 20 μl / well | 3 ml |
● NanoFIT 3D®系列
NanoFIT 3D®系列细胞培养板通过实现线或柱结构的均匀纳米图案来提供仿生界面。这种独特的纳米拓扑结构能够模拟细胞外环境,允许科研人员通过诱导细胞调整其形态和排列,从而更精准地控制和分析特定细胞的反应。它有可能基于纳米图案最大限度地维持和分化细胞,在体内提供类似于ECM(细胞外基质)的环境,使细胞的形态和功能更接近体内真实状态。能维持细胞干性与分化;调节特定细胞靶向;多样化培养形式并且拥有专利技术保障。
| Type | Pattern | Size | Cat. No. |
| Sheet (Polydimethylsiloxane) | Line | 250 nm | N-Line250S |
| Sheet (Polydimethylsiloxane) | Line | 400 nm | N-Line400S |
| Sheet (Polydimethylsiloxane) | Post | 250 nm | N-Post250S |
| Sheet (Polydimethylsiloxane) | Post | 400 nm | N-Post400S |
| Sheet (Polydimethylsiloxane) | Flat | 250 nm | N-Flat250S |
| Sheet (Polydimethylsiloxane) | Flat | 400 nm | N-Flat400S |
| Dish (Polystyrene) | Line | 400 nm | N-Line400P |
● 微珠芯片
微珠芯片是一种专为大规模生产微型珠子而设计的微流控装置。它采用先进的材料和工艺制造,旨在利用胶原蛋白、PEGDA、PLGA等多种水凝胶材料,实现高效、精准的大规模微粒生产。具有卓越的耐化学性;精密的珠子生产能力;材料坚固耐用且可重用。
● PDMS膜
PDMS膜,即聚二甲基硅氧烷膜,作为应用最为广泛的硅基有机聚合物之一,、PDMS膜具有柔软弹性,能够轻松实现大幅度的拉伸变形,且在拉伸过程中仍能保持较好的物理性能和稳定性;具备超薄膜的结构特点,厚度可以做到极薄,在保证基本功能的前提下,最大程度地减少材料的使用和空间的占用;拥有良好的透气性,它允许气体分子自由通过,在生物相容性应用中,能为细胞提供适宜的气体交换环境,促进细胞的生长和代谢;在微流体装置等应用里,也能保证气体的顺畅流通,维持系统的稳定运行;拥有优异的光学透明性,几乎不会对光线的传播产生干扰;对生物组织无毒无害,不会引发明显的免疫反应,可安全地应用于生物医学领域。
<| Material | Diameter | Thickness |
| PDMS | 50 mm / 1.97 inch | 10 μm |
| PDMS | 50 mm / 1.97 inch | 30 μm |
| PDMS | 50 mm / 1.97 inch | 50 μm |
● PDMS定位
PDMS(聚二甲基硅氧烷)作为一种硅基弹性体,拥有高光学透明度,能让研究人员清晰地观察芯片内发生的微观反应和现象;化学稳定性极佳,可在各种化学环境下保持性能稳定;出色的变形性使其能够适应不同的实验需求和操作条件;优异的生物相容性则为生物样本的研究提供了安全可靠的环境。PDMS片上实验室采用了世界领先的PDMS LOC(Lab - on - a - Chip)技术。这项技术实现了在微米尺度上构建具有卓越成型性的纳米·微结构,将复杂的实验室功能集成到一个小小的芯片之上。
● SU-8微型模具
SU-8微型模具是一种感光聚合物模具,专门用于芯片实验室的微图案铸造。它采用环氧树脂基负光刻胶SU-8作为主要材料,通过精密的光刻工艺在晶圆上制造出微图案。相较于其他模具材料,SU-8微型模具的生产速度更快。该模具的高度可高达1,000μm,能够满足制造具有较大高度微结构的需求。这种模具在微流控芯片、生物传感器、微机电系统(MEMS)等领域的生产制造中发挥着重要作用。
| 通道高度 | 晶圆尺寸 | 层 |
| 100 μm 以下 | 4英寸 | 1层 |
| 100 μm 以下 | 6英寸 | 1层 |
| 110 - 200 微米 | 4英寸 | 1层 |
| 110 - 200 微米 | 6英寸 | 1层 |
| 210 - 300 微米 | 4英寸 | 2 层 |
| 310 - 500 微米 | 4英寸 | 超过 2 层 |
| 510 - 800 微米 | 4英寸 | 超过 3 层 |
● 晶圆厂工艺
在半导体产业飞速发展的今天,高效、精准且可靠的制造服务至关重要。MicroFIT凭借其专业的技术和丰富的经验,提供一站式的半导体制造服务,采用分布式外包流程,为客户解决各种制造难题。包括以下服务:
● 光刻:将精心设计的图案精准转移到晶圆上,这是半导体制造的关键起始步骤,为后续的工艺奠定基础,确保图案的高精度和准确性。
● 镀膜:通过各种工艺使金属、聚合物等材料以薄膜形式均匀沉积在硅衬底上,为芯片提供必要的功能层和保护层,增强芯片的性能和稳定性。
● 蚀刻:精确去除必要电路图案外的其余部分,可选择干蚀刻或湿蚀刻方法,以实现对材料的精细加工,塑造出所需的微纳结构。
● 粘接:在半导体制造中,用于将芯片与基板牢固粘合;在微流控器件制造里,用于通道形成后的处理,确保器件各部分之间的可靠连接和密封性。
● 切割:把在半导体晶片加工中制造的器件在图案形成后分离成一定的尺寸,为后续的封装和测试等步骤做准备。
● CMP(化学机械抛光):通过化学和物理过程的结合,对晶圆或玻璃基板进行抛光压平,使表面达到极高的平整度,满足半导体器件制造的严格要求。
" data-original="http://biogradetech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理MicroFIT品牌全系列产品"> 艾美捷科技代理MicroFIT品牌全系列产品
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://biogradetech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:18995651644
邮箱:sales@amyjet.com
0.2983